PATENT CLAIM ANALYSIS

Application Number: 15755854
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["546", "193000"]

Abstract:
The present disclosure relates to a crystalline Forms A, B, and C of (R)—N-((4-methoxy-6-methyl-2-oxo-1,2-di-hydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide, each of which are useful as modulators the activity of histone methyl modifying enzymes. The present disclosure also provides pharmaceutically acceptable compositions comprising the crystalline forms and methods of using said compositions in the treatment of various disorders.

Claim (Index 18):
Crystalline Form B of a compound having the formula wherein the crystalline form B is at least 50% pure by weight, at least 75% pure by weight, at least 80% pure by weight, at least 90% pure by weight, at least 95% pure by weight, or at least 98% pure by weight.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 88.0
- Lexical Diversity: 1.51923
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11672536', '15344426', '13592389', '13248840', '14854760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8007701673057414
- 35 USC 102 Novelty (BERT): 0.536650480419345
- Combined Prediction Score: 0.7743581986171018
- Mean Citation Score: 351.66024000000016
- Max Citation Score: 364.6086
- Similarity Product: 246.3797473767757

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test